Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein

Neuroscience Letters

Volumn 469, Issue 2, 2010, Pages 224-228

  Neuhaus, Winfried ^a   Stessl, Martina ^b   Strizsik, Elisabeth ^b   Bennani Baiti, Barbara ^b   Wirth, Michael ^b   Toegel, Stefan ^b   Modha, Maaya ^b   Winkler, Johannes ^b   Gabor, Franz ^b   Viernstein, Helmut ^b   Noe, Christian R ^b  

^a PharmaCon GmbH   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

ABCB1; Antisense; Blood brain barrier; MDR1; P glycoprotein; PBMEC C1 2

Indexed keywords

ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CELL LINE; CENTRAL NERVOUS SYSTEM AGENTS; DOXORUBICIN; FLUORESCENCE; FLUORESCENT DYES; GENE KNOCKDOWN TECHNIQUES; MICROSCOPY, FLUORESCENCE; OLIGONUCLEOTIDES, ANTISENSE; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RHODAMINE 123; RNA, MESSENGER; SWINE; VERAPAMIL;

EID: 72749110463     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.11.079     Document Type: Article

References (31)

1. Abbott N.J., and Romero I.A. Transporting therapeutics across the blood-brain barrier. Mol. Med. Today 2 (1996) 106-113
2. Bebawy M., and Chetty M. Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia. Bioessays 30 (2008) 183-188
3. Begley D.J. P-glycoprotein: the prototypical BBB efflux transporter. In: Taylor E.M. (Ed). Efflux Transporters and the Blood-Brain Barrier (2005), Nova Science Publishers, Inc., New York
4. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. Differential rat glial cell strain in tissue culture. Science 161 (1968) 370-371
5. Cordon-Cardo C., O'Brien J.P., Casals D., Rittmann-Grauer L., Biedler J.L., Melamed M.R., and Bertino J.R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 695-698
6. Dash A.K., and Elmquist W.F. Separation methods that are capable of revealing blood-brain barrier permeability. J. Chromatogr. B 797 (2003) 241-254
7. Hermann D.M., Kilic E., Spudich A., Krämer S.D., Wunderli-Allenspach H., and Bassetti C.L. Role of drug efflux carriers in the healthy and diseased brain. Ann. Neurol. 60 (2006) 489-498
8. Klinkhammer W., Müller H., Globisch C., Pajeva I.K., and Wiese M. Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators. Bioorg. Med. Chem. 17 (2009) 2524-2535
9. J. Kou, Permeation studies with a set of antidepressants across the blood-brain barrier using an in vitro Transwell™ model, Diploma Thesis, 2007, University of Vienna, Austria.
10. Lauer R., Bauer R., Linz B., Pittner F., Peschek G.A., Ecker G., Friedl P., and Noe C.R. Development of an in vitro blood-brain barrier model based on immortalized porcine brain microvascular endothelial cells. Farmaco 59 (2004) 133-137
11. Lee J.S., Paull K., Alvarez M., Hose C., Monks A., Grever M., Fojo A.T., and Bates S.E. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol. Pharmacol. 46 (1994) 627-638
12. Ling V., Kartner N., Sudo T., Siminovitch L., and Riordan J.R. Multidrug-resistance phenotype in Chinese ovary cells. Cancer Treat. Rep. 67 (1983) 869-874
13. Loscher W., and Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2 (2005) 86-98
14. Neuhaus W., and Noe C.R. Transport at the blood-brain barrier. In: Ecker G.F., and Chiba P. (Eds). Transporters as Drug Carriers (2009), Whiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany 263-298
15. Neuhaus W., Bogner E., Wirth M., Trzeciak J., Lachmann B., Gabor F., and Noe C.R. A novel tool to characterize paracellular transport: the APTS-dextran ladder. Pharm. Res. 23 (2006) 1491-1501
16. Neuhaus W., Plattner V.E., Wirth M., Germann B., Lachmann B., Gabor F., and Noe C.R. Validation of in vitro cell culture models of the blood-brain barrier: tightness characterization of two promising cell lines. J. Pharm. Sci. 97 (2008) 5158-5175
17. Perloff M.D., Störmer E., von Moltke L.L., and Greenblatt D.J. Rapid assessment of P-glycoprotein inhibition and induction in vitro. Pharm. Res. 20 (2003) 1177-1183
18. Piana C., Wirth M., Gerbes S., Viernstein H., Gabor F., and Toegel S. Validation of reference genes for qPCR studies on Caco-2 cell differentiation. Eur. J. Pharm. Biopharm. 69 (2008) 1187-1192
19. Stessl M., Marchetti-Deschmann M., Winkler J., Lachmann B., Allmaier G., and Noe C.R. A proteomic study reveals unspecific apoptosis induction and reduction of glycolytic enzymes by the phosphorothioate antisense oligonucleotide oblimersen in human melanoma cells. J. Proteomics 72 (2009) 1019-1030
20. Suda K., Rothen-Rutishauser B., Günthert M., and Wunderli-Allenspach H. Phenotypic characterization of human umbivilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell. Dev. Biol. Anim. 37 (2001) 505-514
21. Sugiwara I., Kataoka I., Morishita Y., Hamada H., Tsuruo T., Itoyama S., and Mori S. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res. 48 (1988) 1926-1929
22. Teifel M., and Friedl P. Establishment of the permanent microvascular endothelial cell line PBMEC/C1-2 from porcine brains. Exp. Cell Res. 228 (1996) 50-57
23. Vanier G., Szczotka A., Friedl P., Lacouture S., Jacques M., and Gottschalk M. Haemophilus parasuis invades porcine brain microvascular endothelial cells. Microbiology 152 (2006) 135-142
24. von Wedel-Parlow M., Wölte P., and Galla H.J. Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro. J. Neurochem. 111 (2009) 111-118
25. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., and Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19 (2005) 1872-1874
26. Winkler J., Urban E., Losert D., Wacheck V., Pehamberger H., and Noe C.R. A novel concept for ligand attachment to oligonucleotides via a 2′-succinyl link. Nucleic Acids Res. 32 (2004) 710-718
27. Winkler J., Gilbert M., Kocourková A., Stessl M., and Noe C.R. 2′-O-Lysylaminohexyl oligonucleotides: modifications of antisense and siRNA. ChemMedChem 3 (2008) 102-110
28. Winkler J., Martin-Killias P., Plückthun A., and Zangemeister-Wittke U. EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins. Mol. Cancer Ther. 8 (2009) 2674-2683
29. Yang Z.H., and Liu X.D. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro. Epilepsy Res. 78 (2008) 40-49
30. S. Zhang, K. Sagawa, R.D. Arnold, E. Tseng, X. Wang, M.E. Morris, Interactions between the flavanoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo, J. Pharm. Sci. 99 (2010) 430-441.
31. Zibell G., Unkrüer B., Pekcec A., Hartz A.M.S., Bauer B., Miller D.S., and Potschka H. Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition. Neuropharmacology 56 (2009) 849-855